Today, the FDA granted "breakthrough status" to an algorithm that could make screening for heart failure more accessible — both in traditional clinics and telehealth settings. The algorithm uses a deep neural network developed by digital health company Eko and Mayo Clinic. With as little as 15 seconds of electrocardiogram (ECG) data, it can identify Left Ventricular Ejection Fraction (LVEF), a measure that's commonly used to diagnose patients with heart failure.
Read more at Engadget